Pfizer Share Price
Small Cap | Pharmaceuticals and health care | NSE: PFIZER | BSE: 500680
₹4,017.30 -52.60 (-1.29 %)
Last Updated: 04 Apr 2025 03:53 PM
Overview
Open (₹) 4,069.85
High (₹) 4,069.85
Low (₹) 3,955.00
Prev. Close (₹) 4,069.90
Volume 26,065
VWAP (₹) 3,988.45
ROCE (%) 20.46
Industry P/E 46.49
TTM P/E 29.86
P/B Ratio 5.11
Market Cap (₹) Cr.18,378.24
Dividend Yield (%)0.87
EPS (₹) 120.51
ROE15.33%
Sales Growth (%) -9.55
Profit Growth (%)-11.64
Day Range
4,069.854,069.85
52 Week Range
3,867.656,452.85
Historical Returns
Returns (6M)
-28.92 %
Returns (1Y)
-7.17 %
Returns (3Y)
-10.21 %
Returns (5Y)
-5.78 %
Returns (6M)
-28.92 %
Returns (1Y)
-7.17 %
Returns (3Y)
-10.21 %
Returns (5Y)
-5.78 %
SWOT Analysis
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 32.30
MFI 73.49
ATR 165.28
Commodity Channel Index -108.91
ROC125 -32.00
ROC21 -10.36
Williams %R -74.87
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 4,123.04 | 4,195.32 | 4,301.84 | 4,016.52 | 3,944.24 | 3,837.72 | 3,765.44 |
Week Ago | 4,156.26 | 4,217.43 | 4,255.36 | 4,118.33 | 4,057.16 | 4,019.23 | 3,958.06 |
Month Ago | 4,583.51 | 4,743.73 | 4,828.96 | 4,498.28 | 4,338.06 | 4,252.83 | 4,092.61 |
EMA & SMA
4017.30
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 4100.21
9 Day 4122.24
10 Day 4131.43
12 Day 4122.10
14 Day 4148.16
20 Day 4257.26
26 Day 4329.76
50 Day 4670.76
100 Day 5007.78
200 Day 5119.63
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
04 May, 2020 | Anil Gupta | Acquisition | ₹4,200.00 | 25 | NSE |
04 May, 2020 | Anil Gupta | Acquisition | ₹4,050.00 | 100 | NSE |
04 May, 2020 | Anil Gupta | Disposal | ₹4,393.33 | 150 | NSE |
04 May, 2020 | Anil Gupta | Acquisition | ₹4,078.04 | 25 | NSE |
04 May, 2020 | Anil Gupta | Acquisition | ₹4,116.00 | 125 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
17 May, 2024 | Rs.35.0000 per share(350%)Final Dividend | 21 Aug, 2024 | 21 Aug, 2024 |
16 May, 2023 | Rs.5.0000 per share(50%)Special Dividend | 11 Aug, 2023 | 11 Aug, 2023 |
15 May, 2023 | Rs.35.0000 per share(350%)Final Dividend | 11 Aug, 2023 | 11 Aug, 2023 |
Announcements
Date | Source | Detail |
---|---|---|
01 Apr, 2025 | NSE India | PFIZER LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
01 Apr, 2025 | NSE India | Intimation regarding change in Senior Management Personnel of the Company. |
01 Apr, 2025 | BSE India | Intimation regarding change in Senior Management Personnel. |
31 Mar, 2025 | NSE India | Pfizer Limited has informed the Exchange about Closure of Trading Window |
31 Mar, 2025 | NSE India | Pfizer Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
29 Mar, 2025 | NSE India | Pfizer Limited has informed the Exchange regarding ''Update on transfer and assignment of Pfizer s unexpired leasehold rights in the landsituated at Plot No. 16, Trans Thane Creek Industrial Area, Turbhe, Thane and sale ofstructures and buildings constructed thereon, to Zoetis Pharmaceutical ResearchPrivate Limited.''. |
29 Mar, 2025 | BSE India | Update on Transfer and Assignment of MIDC Land and Buildings constructed thereon. |
21 Feb, 2025 | NSE India | Pursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board ofDirectors of the Company at their Meeting held today, that commenced on February 20, 2025at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today,to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited( Mylan ) for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane. |
21 Feb, 2025 | BSE India | Pursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board of Directors of the Company at their Meeting held today, that commenced on February 20, 2025 at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today, to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane. |
14 Feb, 2025 | NSE India | PFIZER LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 28 Jan, 2025 | 31 Jan, 2025 |
Quarterly Results | -- | 22 Oct, 2024 | 28 Oct, 2024 |
Quarterly Results | -- | 23 Jul, 2024 | 29 Jul, 2024 |
Audited Results & Final Dividend | -- | 07 May, 2024 | 17 May, 2024 |
Quarterly Results | -- | 01 Feb, 2024 | 09 Feb, 2024 |
Quarterly Results | -- | 19 Oct, 2023 | 28 Oct, 2023 |
Quarterly Results | -- | 07 Aug, 2023 | 11 Aug, 2023 |
Audited Results & Final Dividend | -- | 08 May, 2023 | 15 May, 2023 |
Quarterly Results | -- | 03 Feb, 2023 | 09 Feb, 2023 |
Quarterly Results | -- | 04 Nov, 2022 | 11 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% |
Foreign Institutions + | 2.74% | 3.03% | 2.77% | 2.13% | 1.87% |
Domestic Institutions + | 16.8% | 15.15% | 14.93% | 15.02% | 14.31% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 16.54% | 17.9% | 18.38% | 18.93% | 19.9% |
Others | 0% | 0% | 0% | 0% | 0% |
About Pfizer
Pfizer is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2193.17 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
MNC Associate
Founded
1950
Managing Director
Ms. Meenakshi Nevatia
NSE Symbol
PFIZER
Pfizer Management
Name | Designation |
---|---|
Mr. Pradip Shah | Chairman & Ind.Director |
Ms. Meenakshi Nevatia | Managing Director |
Mr. P Rengan | Executive Director - Operations |
Mr. Amit Agarwal | Executive Director & CFO |
Mr. Sunil Lalbhai | Independent Director |
Mr. Uday Khanna | Independent Director |
Ms. Meena Ganesh | Independent Director |
Mr. Lakshmanan Krishnakumar | Independent Director |
Ms. Sonia Singh | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,24,682.29 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,52,989.54 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,556.300 - ₹6,448.750 |
Cipla | ₹1,20,795.29 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,09,916.93 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,00,161.69 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Pfizer
What is the share price of Pfizer?
The share price of Pfizer on 04 Apr, 2025 is ₹ 4,017.30.
What is 52W high and 52W low share price of Pfizer?
The highest and lowest 52W share prices of Pfizer are ₹ 6452.850 and ₹ 3867.650
What is the market cap of Pfizer?
The market capitalization of Pfizer as of 04 Apr, 2025 is ₹ 18,378.24 Crores
What is the P/E ratio of Pfizer?
The current P/E ratio of Pfizer as of 04 Apr, 2025 is 46.49
What is the PB ratio of Pfizer?
The PB ratio of Pfizer as of 04 Apr, 2025 is 5.11
Top Gainers
₹109.04
₹90.87 (0.20%)
₹75.34
₹62.79 (0.20%)
₹143.15
₹119.30 (0.20%)
₹3.81
₹3.18 (0.20%)
Top Losers
₹3,206.90
₹3,774.25 (-0.15%)
₹28.50
₹32.80 (-0.13%)
₹950.60
₹1,188.25 (-0.20%)
₹753.20
₹889.55 (-0.15%)
Market Indices
Sensex
₹76,295.36
₹76,617.44 (0.00%)